无并发症阑尾炎6个月内阑尾切除术比非手术治疗更具成本效益且临床结局更优
该研究基于美国全国再入院数据库(2016-2021)比较无并发症阑尾炎患者初次入院接受阑尾切除术或非手术治疗的临床结局与成本效益。共纳入83,533例患者,阑尾切除术组再入院率显著低于非手术组(0.1% vs 6.3%),6个月总成本略高($12,648 vs $11,558),增量成本效益比为每避免一次再入院$17,615。结论认为阑尾切除术在6个月内临床更优且具成本效益。
要点
- 无并发症阑尾炎非手术治疗的6个月再入院率显著高于阑尾切除术(6.3% vs 0.1%)。
- 阑尾切除术6个月总成本略高,但增量成本效益比为每避免一次再入院$17,615。
- 非手术治疗仅适用于特定患者或医疗环境。
核心结论
- 阑尾切除术在6个月内临床结局更优且具成本效益,非手术治疗的初始节省被较高复发率抵消。
研究设计与样本
- 基于美国全国再入院数据库(2016-2021)的回顾性队列研究,纳入83,533例无并发症阑尾炎患者,按初次入院时接受阑尾切除术(68,908例,82.5%)或非手术治疗(14,625例,17.5%)分层。
主要发现
- 非手术组再入院率显著高于手术组(6.3% vs 0.1%)。
- 非手术组初次住院时间更长(中位4天 vs 2天),常规出院比例更低(85.2% vs 95.0%),出院后护理需求更高。
- 院内死亡率罕见但非手术组更高(0.2% vs 0.1%)。
- 6个月总成本非手术组略低($11,558 vs $12,648),但阑尾切除术几乎消除了再入院。
- 增量成本效益比为每避免一次再入院$17,615,概率敏感性分析结果稳健。
临床怎么用
- 对于无并发症阑尾炎,阑尾切除术可作为首选,因其再入院率极低且增量成本可接受。
- 非手术治疗可考虑用于特定患者或医疗环境,但需告知其较高的再入院风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Nonoperative management with antibiotics is an alternative to appendectomy for patients with uncomplicated appendicitis. Nonoperative management may reduce initial costs and recovery time, but concerns about recurrence and delayed surgery raise questions about its long-term value. We compared clinical outcomes and determined the cost-effectiveness of appendectomy and nonoperative management using a national data set. METHODS: We selected patients with uncomplicated appendicitis from the Nationwide Readmissions Database (2016-2021). Patients were stratified by appendectomy or nonoperative management at index admission. Outcomes included 6-month readmissions, in-hospital mortality, discharge disposition, and length of stay. Costs included index admission, readmissions, and total expenditures. Cost-effectiveness was assessed as the incremental cost-effectiveness ratio, defined as incremental cost per readmission avoided. Probabilistic sensitivity analysis and cost-effectiveness acceptability curves tested robustness. RESULTS: Among 83,533 patients, 68,908 (82.5%) had appendectomy and 14,625 (17.5%) nonoperative management. Readmissions were higher in nonoperative management (6.3% vs 0.1%). Nonoperative management patients had longer index stays (median 4 vs 2 days), less routine discharge (85.2% vs 95.0%), and greater need for postdischarge care. In-hospital mortality was rare but higher with nonoperative management (0.2% vs 0.1%). Total 6-month costs were modestly lower with nonoperative management ($11,558 vs $12,648), but appendectomy nearly eliminated readmissions. The incremental cost-effectiveness ratio was $17,615 per readmission avoided, with robust sensitivity analyses. CONCLUSIONS: Appendectomy provided definitive cure with near-zero readmissions and an acceptable incremental cost. Nonoperative management offered initial savings, but higher recurrence limited its value. Appendectomy was clinically superior and cost-effective within 6 months, whereas nonoperative management may be reasonable only in select patients or settings.
引用
- Kwon J, Zakhary B, Coimbra BC, et al. Cost-effectiveness and superior clinical outcomes of appendectomy are evidenced within 6 months of the index admission for uncomplicated appendicitis compared to nonoperative management. Surgery. 2026. PMID: 41849845. doi:10.1016/j.surg.2026.110150
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。